Dental equipment leader, completes important acquisition

September 24, 2024  Source: drugdu 75

"/Dental equipment pioneer Henry Schein announced that it has completed the acquisition of Shield Healthcare Inc. Shield Healthcare Inc. is a device company that directly provides home care medical products to patients. Henry Schein announced this transaction last year.

01 Enters the field of household appliances
In August 2023, Henry Schein announced that he had signed an agreement to acquire a majority stake in Shield Healthcare, Inc.

On the basis of Henry Schein's acquisition of Prism Medical Products LLC in 2021, Shield Healthcare will expand Henry Schein's existing medical business by providing diversified product series, including incontinence, urology, ostomy, enteral nutrition, advanced wound care and diabetes products. In addition, it will provide patients with continuous blood glucose monitoring devices directly at home.

As the healthcare industry continues to shift towards home care, we have expanded our business of directly providing medical products to patients through our partnership with Shield Healthcare, "said Stanley M. Bergman, Chairman/CEO of Henry Schein

It is reported that as early as 2021, Henry Schein successfully acquired Prism Medical Products LLC to enter the field of home healthcare products. This acquisition of Shield Healthcare represents the company's further investment in the home care medical supplies market. Through this acquisition, Henry Schein's home healthcare product platform will have an annual revenue base of over $300 million.

02 Established Home Medical Equipment Enterprise
Shield Healthcare was founded in 1957 and is headquartered in Valencia, California. Initially founded as a pharmacy, it was acquired by medical device manufacturer C. in 1982 R. Bard was acquired by Kobayashi Pharmaceutical Co., Ltd., a pharmaceutical company and distributor, in September 1990. In November 2006, the company's executive management team established a company called Dharma Ventures Group to acquire a controlling stake in Kobayashi Pharmaceutical Co., Ltd.

In 2007, after review by the CHAP Review Committee, Shield Healthcare officially became a leader in providing high-quality products and services to the home healthcare market. After years of development, Shield Healthcare now has branches in Arkansas, California, Colorado, Illinois, Ohio, Texas, and Washington.

With more than 65 years of pharmaceutical and medical supply experience, Shield Healthcare has become an industry leader in household medical products such as urinary incontinence, urology, ostomy, enteral nutrition, advanced wound and diabetes products, and continuous glucose monitoring equipment.

Shield Healthcare will operate as part of Henry Schein, and the company's current controlling shareholder, including members of the management team, will retain the remaining minority stake in the company.

03 The world's largest dental company
HENRY SCHEIN was founded in 1932 and has a history of nearly a century. Its headquarters is located in Melville, New York, USA. It is the world's largest provider of dental and animal health products and services, mainly based on clinics.

In 2013, the company also established its first joint venture named after HENRY SCHEIN in China, known as Hanruixiang Sunshine. It has a well-known Peking University Stomatological Hospital and maintains long-term cooperation with companies such as Japan's Matsumoto Corporation, Germany's DMG Corporation, Germany's CAMLOG Corporation, and Canada's IBC Corporation.

At the beginning of its establishment, the company was just a small supplier of medical supplies to dental clinics in New York, and over time, the company gradually expanded in size. In 1997, it became the world's largest distributor of dental equipment and supplies through the acquisition of Sullivan Dental Products for $318 million. Over the next 25 years, the company acquired more than 40 enterprises, continuously consolidating its position as the "leader".

In addition, the company has also formulated the "BOLD+1" strategy. The plan emphasizes enhancing the company's market share and influence in the dental specialty field through acquisitions, mergers and strategic partnerships. Among them, BOLD refers to expanding business, innovating products, leading the market, and developing global business. And+1 represents the addition of a new capability or resource through acquisition and cooperation.

HENRY SCHEIN believes that through strategic acquisitions and collaborations, the company can continuously expand its product line, strengthen market penetration, and provide customers with more and better dental products as well as higher quality services.

Through these acquisitions, HENRY SCHEIN has grown into the world's largest clinic based provider of dental and animal health healthcare products and services. In addition to its own branded products, it also has over 300000 branded products such as BioHorizons, Camlog, Biotech Dental, and medics medical, covering areas ranging from dental instruments and equipment, medical instruments and consumables, pharmaceuticals, digital solutions to medical laboratory equipment and consumables.

With a rich product line, the company has established a strong business network worldwide. Data shows that Hanruixiang has affiliated institutions in 32 countries and regions worldwide, providing services to over one million dental and medical clients. Since becoming a listed company in 1995, its sales have grown at a compound annual growth rate of approximately 12.1%, reaching $12.6 billion in 2022 with net sales of $12.647 billion. In 2021, it was $12.401 billion. The net profit attributable to the company for the whole year was 538 million US dollars, compared to 631 million US dollars in the previous year.

Source: http://qixieke.com/Font/index/detailPage.html?id=3198-142

By editor
Share: 

your submission has already been received.

OK

Subscribe

Please enter a valid Email address!

Submit

The most relevant industry news & insight will be sent to you every two weeks.